Cargando…
A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus
The worldwide prevalence of herpes simplex virus (HSV) and the shortage of efficient vaccines and novel therapeutic strategies against HSV are widely global concerns. The abundance on the virion and the major stimulus for the virus-neutralizing antibodies makes gD a predominant candidate for cure of...
Autores principales: | Du, Ruikun, Wang, Lili, Xu, Hao, Wang, Zhiying, Zhang, Tao, Wang, Manli, Ning, Yunjia, Deng, Fei, Hu, Zhihong, Wang, Hualin, Li, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113901/ https://www.ncbi.nlm.nih.gov/pubmed/29061442 http://dx.doi.org/10.1016/j.antiviral.2017.10.013 |
Ejemplares similares
-
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023) -
Structural basis for the antibody neutralization of Herpes simplex virus
por: Lee, Cheng-Chung, et al.
Publicado: (2013) -
Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
por: Liu, Xiao-Qin, et al.
Publicado: (2018) -
Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody
por: Krawczyk, Adalbert, et al.
Publicado: (2015) -
Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses
por: Blevins, Tamara P., et al.
Publicado: (2015)